New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SNDL Inc.
SNDL
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

491M

Drug Manufacturers - Specialty & Generic

Next Earning date - 19 Mar 2025

491M

Drug Manufacturers - Specialty & Generic

Next Earning date - 19 Mar 2025

1.85USD

Shape-0.01 ( -0.54%)
Market Closed (as of Feb 10, 21:00 EDT)
favorite-chart

Relative Strenght

44
favorite-chart

Volume Buzz

-11%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

37%

Quote Panel

Shape
Updated February 11, 2025
1W -0.54 % 1M 2.78 % 3M -7.50 % 1Y 34.06 %

Key Metrics

Shape
  • Market Cap

    491.18M


  • Shares Outstanding

    265.50M


  • Share in Float

    262.01M


  • Dividende

    0


  • Earning Date

    19 Mar 2025


  • Price Target

    1.85


  • Average Volume

    2.20M


  • Beta

    3.197


  • Range

    1.3-2.93


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.sndlgroup.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

SNDL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$961M

Shape306%

2025-Revenue

$0.04

Shape156%

2025-EPS

$680M

Shape-33392%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Canaccord Genuity

upgrade

Previous: Not converted

2022-08-16

Now: Buy

Cantor Fitzgerald

initialise

Previous: Not converted

2021-03-10

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.70
vs -0.27

Q1.23

arrow
arrow

N/A

-0.07
vs -0.20

Q2.23

arrow
arrow

N/A

-0.08
vs -0.08

Q3.23

arrow
arrow

N/A

-0.06
vs -0.02

Q4.23

arrow
arrow

N/A

-0.32
vs -0.70

Q1.24

arrow
arrow

N/A

-0.01
vs -0.07

Q2.24

arrow
arrow

N/A

-0.01
vs -0.08

Q3.24

arrow
arrow

N/A

-0.05
vs -0.06

Q4.24

arrow
arrow

N/A

-0.02
vs -0.32

Q1.25

arrow
arrow

N/A

-0.03
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+958%

240.4M  vs 22.7M

Q1.23

arrow
arrow

+1050%

202.5M  vs 17.6M

Q2.23

arrow
arrow

+9%

244.5M  vs 223.7M

Q3.23

arrow
arrow

+3%

237.6M  vs 230.5M

Q4.23

arrow
arrow

+3%

248.4M  vs 240.4M

Q1.24

arrow
arrow

-2%

197.8M  vs 202.5M

Q2.24

arrow
arrow

-7%

228.1M  vs 244.5M

Q3.24

arrow
arrow

0%

236.9M  vs 237.6M

Q4.24

arrow
arrow

+0%

248.5M  vs 248.4M

Q1.25

arrow
arrow

+4%

205.1M  vs 197.8M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-12%

-0.12
vs -0.07

Q1.23

arrow
arrow

-3%

-0.03
vs -0.12

Q2.23

arrow
arrow

-2%

-0.02
vs -0.03

Q3.23

arrow
arrow

-2%

-0.02
vs -0.02

Q4.23

arrow
arrow

-7%

-0.07
vs -0.02

Q1.24

arrow
arrow

0%

-0.00
vs -0.07

Q2.24

arrow
arrow

0%

-0.00
vs -0.00

Q3.24

arrow
arrow

-2%

-0.02
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

151

151
vs 56

170%

Q2.21

arrow
arrow

173

173
vs 151

15%

Q3.21

arrow
arrow

154

154
vs 173

-11%

Q4.21

arrow
arrow

163

163
vs 154

6%

Q1.22

arrow
arrow

164

164
vs 163

1%

Q2.22

arrow
arrow

124

124
vs 164

-24%

Q3.22

arrow
arrow

1

1
vs 124

-99%

Q4.23

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News